信铭生命科技(00474) - 2026 - 中期业绩

Financial Performance - For the six months ended September 30, 2025, the company reported revenue of HKD 29 million, an increase of 26.1% compared to HKD 23 million for the same period in 2024[3]. - The company achieved a profit from continuing operations of HKD 386 million, compared to a loss of HKD 114 million in the previous year, indicating a significant turnaround[4]. - Total comprehensive income for the period was HKD 313 million, a recovery from a loss of HKD 173 million in the same period last year[4]. - The basic earnings per share from continuing operations was HKD 5.27, compared to a loss per share of HKD 1.59 in the previous year[5]. - The group’s total income for the six months ended September 30, 2025, was HKD 465 million, compared to a loss of HKD 3 million in the same period last year[19]. - Basic and diluted earnings per share for the period were HKD 5.27, compared to a loss of HKD (1.91) in the previous year[27]. Expenses and Costs - The company reported administrative expenses of HKD 55 million, which increased from HKD 23 million in the previous year, reflecting higher operational costs[3]. - The financing costs decreased to HKD 41 million from HKD 57 million, showing improved financial management[3]. - The group reported other income of HKD 5 million for the six months ended September 30, 2025, compared to HKD 8 million in the previous year, indicating a decrease of 37.5%[19]. - The group incurred interest expenses of HKD 41 million for the six months ended September 30, 2025, down from HKD 57 million in the same period last year, reflecting a reduction of approximately 28.1%[20]. - Administrative expenses increased to approximately HKD 55 million from HKD 23 million in the previous year, largely due to legal and professional fees related to refinancing[41]. Assets and Liabilities - As of September 30, 2025, total assets amounted to HKD 1,722 million, a decrease from HKD 3,243 million as of March 31, 2025[6]. - Total liabilities were HKD 1,352 million, compared to HKD 2,499 million previously[7]. - Current liabilities totaled HKD 229 million, a significant reduction from HKD 1,906 million[7]. - The company's net assets decreased to HKD 370 million from HKD 744 million[7]. - The total equity attributable to owners of the company was HKD 370 million, down from HKD 744 million[7]. - As of September 30, 2025, the group had current assets of approximately HKD 453 million and current liabilities of approximately HKD 229 million[44]. Market Strategy and Operations - The company plans to expand its market presence and invest in new technologies to drive future growth[2]. - The company is focusing on enhancing its product offerings and exploring potential mergers and acquisitions to strengthen its market position[2]. - The company completed the sale of its subsidiary, resulting in a fundamental change in its business model and strategy, now focusing on property leasing[34]. - The core business is centered around high-quality commercial properties in central London, which are leased to reputable international companies[35]. - The company is optimistic about the UK property market recovery and plans to upgrade properties to enhance tenant experience and market value[60]. - Most tenants have expressed willingness to renew leases at potentially higher rental levels, ensuring stable long-term revenue sources[61]. Shareholder and Governance - The company did not recommend the payment of an interim dividend for the six months ended May 12, 2025, and September 30, 2024[25]. - The company did not declare an interim dividend for the period, consistent with the previous year[50]. - The board of directors includes two executive directors, one non-executive director, and three independent non-executive directors[69]. - The company has adhered to corporate governance principles and standards throughout the reporting period[62]. Financial Reporting and Compliance - The financial statements are unaudited and presented in Hong Kong dollars (HKD)[10]. - The group did not apply any new or revised Hong Kong Financial Reporting Standards that have been issued but are not yet effective, and is currently assessing their potential impact[12]. - The group’s financial statements are prepared in accordance with the Hong Kong Financial Reporting Standards and the relevant disclosure requirements of the Listing Rules[12]. - The mid-term performance announcement will be published on the Hong Kong Stock Exchange website and the company's website[68]. - The mid-term report will be sent to shareholders and published on the Hong Kong Stock Exchange and the company's website at the appropriate time[68]. Employee and Operational Changes - The company had 41 employees as of September 30, 2025, a decrease from 146 employees as of March 31, 2025[53].